US Physical Therapy
USPH
243 hedge funds and large institutions have $1.4B invested in US Physical Therapy in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 91 increasing their positions, 82 reducing their positions, and 22 closing their positions.
45% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 22
11% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 82
3% more funds holding
Funds holding: 236 → 243 (+7)
3.03% less ownership
Funds ownership: 103.65% → 100.62% (-3%)
21% less capital invested
Capital invested by funds: $1.76B → $1.4B (-$362M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
69% less call options, than puts
Call options by funds: $147K | Put options by funds: $481K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$32.5M |
| 2 |
Renaissance Technologies
New York
|
+$6.22M |
| 3 |
Morgan Stanley
New York
|
+$6.02M |
| 4 |
Rockefeller Capital Management
New York
|
+$5.02M |
| 5 |
Goldman Sachs
New York
|
+$4.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$87.3M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$19.5M |
| 3 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$13.3M |
| 4 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$7.97M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.53M |
USPH Hedge Fund Activity: Q2 2024 in Review
243 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in US Physical Therapy (USPH) for Q2 2024, worth a combined $1.4B — down 21% from $1.76B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new USPH positions and 22 closed out — a net gain of 10 holders — while 91 added to existing stakes and 82 trimmed.
The largest buyer was Barclays, adding an estimated $32.5M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $87.3M sold.
- 243 institutional investors held US Physical Therapy (USPH) as of Q2 2024, up from 236 in Q1 2024.
- Funds reported $1.4B of US Physical Therapy stock for Q2 2024, down 21% quarter-over-quarter.
- 32 funds opened new US Physical Therapy positions in Q2 2024 and 22 closed out, a net change of +10 holders.
- The largest US Physical Therapy buyer in Q2 2024 was Barclays, an estimated $32.5M added.
- The largest US Physical Therapy seller in Q2 2024 was T. Rowe Price Investment Management, an estimated $87.3M sold.
Based on aggregated 13F filings for Q2 2024.